Second Annual Meeting

πŸ“’The RITA-MI2 project Second Annual Meeting took place on Wednesday 21st June 2023, on-line. πŸ–₯πŸ“†πŸ“Š A great opportunity for the 25 participants from all across Europe to discuss about the project’s progress, 2 years after its launch. πŸ₯πŸ’—πŸ©ΊπŸ‘©β€βš•οΈπŸ‘©β€πŸ”¬πŸ§ͺπŸ”œ LinkedIn posts here and...

1st Annual Meeting

The RITA-MI2 project First Annual Meeting took place on Tuesday 21st June 2022, on-line. πŸ–₯πŸ“†πŸ“Š 23 project members working for one of the 13 project partners gathered one afternoon to present and discuss about the project’s first year and the next steps to be taken...

RITA-MI2 in clinical

The RITA-MI2 trial is listed on, under registration number NCT05211401.   Study Description   Brief Summary The main objective is to compare the effect of a single injection of two doses of rituximab versus placebo on 6 months left...

Newsflash – 1st patient included

The RITA-MI2 trial French CRA team sent a newsflash to all French recruiting centres in July 2022. Have a look ! Newsflash 22 07 2022

RITA-MI2 clinical trial launched

πŸŽ‰The RITA-MI2 clinical trial has been launched today at Bichat Hospital, Paris.πŸ₯πŸ‘©β€βš•οΈ More information to come